Inactive Instrument
Guided Therapeutics Inc Stock OTC Bulletin Board
Stocks
US40171F1057
Advanced Medical Equipment & Technology
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| Jul. 14 | Guided Therapeutics, Inc. Announces New Agreement With Yuanshuo Medical Instruments Corporation | CI |
| Jun. 16 | Guided Therapeutics Files Premarket Approval Application Clinical Report with FDA | CI |
| Market Cap | 26.55M 23.26M 21.51M 19.77M 37.36M 2.56B 37.93M 257M 101M 1.25B 99.68M 97.5M 4.31B | P/E 2024 |
-3x | P/E 2025 | -12.7x |
|---|---|---|---|---|---|
| Enterprise Value | 29.42M 25.78M 23.84M 21.91M 41.41M 2.84B 42.04M 285M 112M 1.39B 110M 108M 4.78B | EV / Sales 2024 |
1,649x | EV / Sales 2025 | 64.4x |
| Free-Float |
63.48% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Faupel
CEO | Chief Executive Officer | 70 | 2023-03-05 |
| Chief Tech/Sci/R&D Officer | 70 | 2010-12-01 |
| Director | Title | Age | Since |
|---|---|---|---|
John Imhoff
BRD | Director/Board Member | 76 | 2006-04-09 |
Richard Blumberg
BRD | Director/Board Member | 69 | 2016-11-09 |
Mark Faupel
BRD | Director/Board Member | 70 | 2016-11-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.17% | -0.16% | +26.88% | -1.74% | 198B | ||
| -1.33% | +1.03% | +5.82% | -17.54% | 144B | ||
| +2.24% | -13.18% | -31.90% | +0.99% | 122B | ||
| -0.59% | -2.23% | -57.77% | -16.37% | 65.44B | ||
| -0.85% | -7.82% | +11.13% | -7.23% | 49.36B | ||
| +0.65% | +2.20% | -23.34% | -30.88% | 44.74B | ||
| -0.91% | -3.00% | +14.27% | +5.83% | 37.13B | ||
| -3.10% | -5.02% | +24.35% | +27.66% | 36.23B | ||
| -0.19% | -2.58% | -23.00% | -8.92% | 28.7B | ||
| Average | -0.70% | -2.81% | -5.95% | -5.35% | 80.68B | |
| Weighted average by Cap. | -0.73% | -2.62% | -1.75% | -6.34% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 7K 6.13K 5.67K 5.21K 9.85K 675K 10K 67.8K 26.56K 330K 26.28K 25.71K 1.14M | 767K 672K 622K 571K 1.08M 73.97M 1.1M 7.43M 2.91M 36.19M 2.88M 2.82M 125M |
| Net income | -2.42M -2.12M -1.96M -1.8M -3.4M -233M -3.45M -23.41M -9.17M -114M -9.08M -8.88M -393M | -3.2M -2.8M -2.59M -2.38M -4.5M -308M -4.57M -30.95M -12.13M -151M -12M -11.74M -519M |
| Net Debt | 1.77M 1.55M 1.44M 1.32M 2.49M 171M 2.53M 17.15M 6.72M 83.56M 6.65M 6.5M 288M | 2.88M 2.52M 2.33M 2.14M 4.05M 277M 4.11M 27.86M 10.91M 136M 10.8M 10.56M 467M |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
















